Repair of osteopenia in children with juvenile rheumatoid arthritis
References (16)
- et al.
Abnormalities in serum osteocalcin values in children with chronic rheumatic diseases
J Pediatr
(1990) - et al.
25-Hydroxyvitamin D therapy in children with active juvenile rheumatoid arthritis: short-term effects on serum osteocalcin levels and bone mineral density
J Pediatr
(1991) - et al.
Hypercalciuria in children with juvenile rheumatoid arthritis: association with hematuria
J Pediatr
(1985) - et al.
Correlation of plasma interleukin-1 levels with disease activity in rheumatoid arthritis
Lancet
(1988) - et al.
Bone mineral content in normal U.S. whites
- et al.
Quarterly changes in BMC at the radius and spine in young adults
- et al.
Measurement of bone mineral content of the lumbar spine by dual energy x-ray absorptiometry in normal children: correlations with growth parameters
J Clin Endocrinol Metab
(1990) - et al.
Critical years and stages of puberty for spinal and femoral bone mass accumulation during adolescence
J Clin Endocrinol Metab
(1991)
Cited by (59)
Osteoporosis associated with rheumatologic disorders
2020, Marcus and Feldman’s OsteoporosisBisphosphonates for Prevention of Bone Loss in Glucocorticoid-Treated Young People
2019, EClinicalMedicineThe prevention and treatment of glucocorticoid-induced osteopaenia in juvenile rheumatic disease: A randomised double-blind controlled trial
2019, EClinicalMedicineCitation Excerpt :Steroids reduce peak bone mass and fracture risk increases as steroid dose increases [3,9,10]. Many more children receive recurrent courses of steroids for other common diseases such as asthma, with an associated increased risk of fracturing [11,12]. Children receiving steroids can, unlike adults, dramatically increase their BMD when their disease is brought under control [13].
The impact of underlying disease on fracture risk and bone mineral density in children with rheumatic disorders: A review of current literature
2016, Seminars in Arthritis and RheumatismCitation Excerpt :This is problematic in that it is likely not appropriate to group children with widely disparate disease and/or treatment durations, reducing the ability to identify relationships and differences between groups. Some authors have taken the important step of presenting longitudinal data [9,27,29,31,38,40,55–57,59–61,65,74,75,77,81,85,96]. Long-term, longitudinal follow-up will be needed to completely understand the impact of childhood inflammatory disease on the adult skeleton.
Pharmacology and Drug Therapy: Nonbiologic Therapies
2015, Textbook of Pediatric RheumatologyOsteoporosis Associated with Rheumatologic Disorders
2013, Osteoporosis: Fourth Edition